inno.N studies various fields.
Based on experience and know-how in new drug development, inno.N has developed the new drug 'K-CAB Tab.', a new drug for gastroesophageal reflux disease in Korea. We are expanding the pipeline by focusing on digestive, cancer, and immune diseases with high market unmet needs. In addition, we are continuing to “Open Innovation” with excellent R & D venture companies in Korea, Japan, the US and Europe to speed up the development of promising new drugs while expanding the R & D network.